Nilutamide-d6
Modify Date: 2024-01-08 06:24:28
Nilutamide-d6 structure
|
Common Name | Nilutamide-d6 | ||
|---|---|---|---|---|
| CAS Number | 1189477-66-4 | Molecular Weight | 323.25800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H4D6F3N3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Nilutamide-d6Nilutamide-d6 (Nilandron-d6) is the deuterium labeled Nilutamide. Nilutamide (Nilandron) is a non-steroidal anti-androgen drug proposed in the research of metastatic prostatic carcinoma[1][2]. |
| Name | 3-[4-nitro-3-(trifluoromethyl)phenyl]-5,5-bis(trideuteriomethyl)imidazolidine-2,4-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Nilutamide-d6 (Nilandron-d6) is the deuterium labeled Nilutamide. Nilutamide (Nilandron) is a non-steroidal anti-androgen drug proposed in the research of metastatic prostatic carcinoma[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
[3]. Ask K, et al. Metabolism of nilutamide in rat lung. Biochem Pharmacol. 2006 Jan 12;71(3):377-85. |
| Molecular Formula | C12H4D6F3N3O4 |
|---|---|
| Molecular Weight | 323.25800 |
| Exact Mass | 323.10000 |
| PSA | 98.72000 |
| LogP | 2.67660 |
| Nilutamide-d6 |
| Nilandron-d6 |
| Nilandrone-d6 |
| Anandron-d6 |